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Sequencing and computer analysis of the left (52,283 bp) and right (49,649 bp) variable DNA regions of the cowpox virus
strain GRI-90 (CPV-GRI) has revealed 51 and 37 potential open reading frames (ORFs), respectively. Comparison of the
structure–function organization of these DNA regions of CPV-GRI with those previously published for corresponding regions
of genomes of vaccinia virus, strains Copenhagen (VAC-COP) and Western Reserve (VAC-WR); and variola major virus, strains
India-1967 (VAR-IND), Bangladesh-1975 (VAR-BSH); and alastrim variola minor virus, strain Garcia-1966 (VAR-GAR), was
performed. Within the left terminal region under study, an extended DNA sequence (14,171 bp), unique to CPV, has been found.
Within the right region of the CPV-GRI genome two segments, which are unique to CPV DNA (1579 and 3585 bp) have been
found. Numerous differences have been revealed in the genetic structure of CPV-GRI DNA regions, homologous to fragments
of the genomes of the above-mentioned orthopoxvirus strains. A cluster of ORFs with structural similarity to immunomodu-
latory and host range function of other poxviruses have also been detected. A comparison of the sequences of ORF B, crmA,
crmB, crmC, IMP, and CHO hr genes of CPV Brighton strain (CPV-BRI) with the corresponding genes in strain GRI-90 have
revealed an identity at the amino acid level ranging from 82 to 96% between the two strains. The findings are significant in
light of the recent demonstration of CPV as an important poxvirus model system to probe the precise in vivo role(s) of the
unique virally encoded immunomodulatory proteins. Also, the presence of a complete and intact repertoire of immunomodu-
latory proteins, ring canal proteins family, and host range genes indicates that CPV may have been the most ancient of all
studied orthopoxviruses. © 1998 Academic Press
INTRODUCTION
The massive vaccination program with vaccinia virus
(VAC) made it possible for the complete eradication of
smallpox due to variola virus (VAR), one of the deadly
human diseases (Fenner et al., 1989). Comparative
analysis of genome organization of VAR and VAC
(Shchelkunov, 1995; Shchelkunov and Totmenin, 1995)
led us to believe that VAR and VAC had evolved from a
common ancestor, though independently from each
other. This conclusion is based, in particular, on the fact
that these viruses contain genome segments unique
both to VAR and VAC. Previously, attempts had been
made to build up a pattern of evolutionary relationship of
orthopoxviruses by using the data obtained from restric-
tion enzyme analysis of genomes of different orthopox-
viruses (Fenner et al., 1989). These attempts, however,
did not provide an answer either to the question of which
of the orthopoxviruses is most related to precursor virus
or to the question of whether a new virus with the
epidemiological characteristics similar to those of VAR
might emerge in nature. Cowpox virus (CPV) qualifies as
a possible candidate for such an ancestor, because it
has the most extensive genome among all orthopox-
viruses (Esposito and Knight, 1985). Therefore, compar-
ative studies on genome organization of CPV, VAR, and
VAC have been a focus of our interest. Here we report
the results of an analysis of the 52.3-kbp DNA of the left
and the 49.6-kbp DNA of the right terminal regions of
CPV genome, strain GRI-90 (CPV-GRI), and compare
these sequences with corresponding DNA regions of
VAC, strains Copenhagen (VAC-COP) (Goebel et al.,
1990) and WR (VAC-WR) (Earl and Moss, 1990), as well as
the DNA of variola major virus, strains India-1967 (VAR-
IND) (Shchelkunov et al., 1993d, 1994, 1996), Bang-
ladesh-1975 (Massung et al., 1994), and alastrim variola
minor virus, strain Garcia-1966 (VAR-GAR) (Massung et
al., 1996; Shchelkunov et al., in preparation).
RESULTS AND DISCUSSION
In studying genome organization of different species
of orthopoxviruses, the analysis of the left and right
variable terminal regions of the genome is of particular
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interest, since the central region is highly conserved
among all orthopoxviruses (Fenner et al., 1989). The
analysis of the nucleotide sequences of CPV-GRI left and
right terminal DNA segments with sizes of 52,283 and
49,649 bp, respectively, has been reported here. Com-
puter analysis of these regions of viral genome made it
possible to identify 51 potential open reading frames
(ORFs) in the left and 37 ORFs in the right CPV genome
termini with a size of 60 amino acid residues (aa) or more
(Figs. 1–3; Table 1).
The terminal CPV-GRI regions were compared to cor-
responding DNA regions of VAC-COP (Goebel et al.,
1990), VAC-WR (Kotwal and Moss, 1988b, 1989; Earl and
Moss, 1990; Smith et al., 1991), VAR-IND (Shchelkunov et
al., 1993d, 1994, 1996), and VAR-GAR (Massung et al.,
1996; Shchelkunov et al., in preparation). The results of
these analyses are presented in Figs. 2 and 3. These
regions comprise inverted terminal repeats (ITRs) and
unique sequences. The genomes of VAR-IND and VAR-
BSH are very similar (Shchelkunov et al., 1995) and,
therefore, only relevant genes and DNA segments of
these strains were comparatively studied.
Inverted terminal repeats
The ITRs are hypervariable regions of the orthopoxvi-
rus genome, since these regions reveal numerous struc-
tural differences not only between strains of one and the
same species of orthopoxviruses but also between sub-
clones of the same strain (Fenner et al., 1989). The ITR
length also varies among different vaccinia virus strains,
e.g., VAC strain Lister, 11.6 kbp; VAC-WR, 10.5 kbp; VAC-
COP, 12 kbp (Goebel et al., 1990); rabbitpox virus, 5.3 kbp;
cowpox virus strain Brighton (CPV-BRI), 9.7 kbp (Fenner
et al., 1989); CPV-GRI, 8.4 kbp. With different VAR strains,
the length of ITR varies from 583 to 1051 bp (Massung et
al., 1995). Despite such sharp differences, there are a
number of structures typical of this region: a terminal
hairpin, two conserved nonrepeating sequences, NRI
and NRII, and two sets of short tandem repeats flanking
the NRII region.
ITR begins with the terminal hairpin that covalently
closes the two genomic DNA strands. The length of the
hairpin is 102 nucleotides for VAC-COP, 104 for VAC-WR,
and 103 for VAR-BSH (Baroudy et al., 1983; Goebel et al.,
1990; Massung et al., 1994). Analysis of terminal hairpin
nucleotide sequences showed that they consisted al-
most completely of adenine and thymine residues and
could be characterized as having incomplete pairing and
existing in two isomeric forms, F and S, in which the
sequence of the F form is an inverted complementary
sequence of the S form (Baroudy et al., 1982). Thus, the
ITR region also covers these structures. For CPV-GRI, we
identified a sequence of 20 nucleotides within the hairpin
that almost completely corresponds to published data
(Massung et al., 1994).
The length of the NRI and NRII regions of CPV-GRI ITR
are 86 and 328 bp, respectively. The fact that these
regions are found within all orthopoxviruses studied and
are similar in size with a high degree of homology (93 to
98%) may be indicative that these regions and the termi-
nal hairpins within different orthopoxviruses have an
important functional role in replication of viral DNA. Thus,
in the NRI region a sequence was identified that is
essential for telomere resolution of concatameric repli-
cation intermediates (Stuart et al., 1992).
Short tandem repeat regions are extremely heteroge-
neous in length (Fig. 4) but they consist of rather con-
served subunits with a size of 70 and 54 bp. In addition,
VAC-COP and VAC-WR were found to bear two repeats
each, with a size of 125 bp. Subunits of 54 and 125 bp
may have appeared due to superposition of certain re-
gions of the 70-bp subunit; this would indicate the pres-
ence of a complex cycle of processes of deletions and
duplications within the tandem repeats. The complexity
of these processes is most observable with the CPV-BRI
(Pickup et al., 1982), in which the number of subunits in
both the first and the second block of tandem repeats is
different from those in similar regions in CPV-GRI (see
Fig. 4).
The first block of tandem repeats, located between the
NRI and NRII regions, consists of only 70-bp subunits
(except CPV-BRI). Their number varies: VAC-COP—39;
VAC-WR—13; CPV-GRI—7, different VAR strains—1 to 5
(Massung et al., 1995). The last repeat, bordering the
NRII region is reduced within VAC by 18 bp and within
VAR and CPV-GRI by 24 bp (see Fig. 4).
The second block of tandem repeats is more hetero-
geneous, while containing both 70- and 54-bp subunits
(VAC additionally reveals subunits with a size of 125 bp).
In most VAR strains, the boundary of ITR is found almost
immediately after the NRII region, and there is no other
block of tandem repeats within the left terminus. The
sequence of subunits within the second block comprises
in VAC-WR 19 repeats of 70 bp each, 2 repeats of 125 bp
each, a truncated repeat of 70 bp, and 8 repeats of 54 bp
each; this block ends with a shortened 70-bp repeat.
VAC-COP has similar sequences; the only difference
being that instead of 19 repeats of 70 bp it has only 1
FIG. 1. HindIII restriction map of the cowpox virus CPV-GRI genome. Black blocks indicate the sequenced regions of the viral DNA.
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TABLE 1
The Potential Open Reading Frames (ORF) of Cowpox (CPV), Vaccinia (VAC), and Variola (VAR) Viruses in the Genomic Regions Analyzed
CPV-GRI VAC-COP VAR-IND
Amino acid identity/
Size of sequence
compared (aa)b
Protein function (homology)c ReferencesORF
Protein
size, (aa) ORF
Protein
size, (aa) ORF
Protein
size, (aa) GRI/COP GRI/IND
Left terminal genome region
D1La 255 C23La 244 — — 97.1/242 Most abundant protein
secreted from the cell
Patel et al. (1990); Martinez-
Pomares et al. (1995)
D1La 255 C22.5La 57 — — 92.3/13
D2La 351 C22La 122 — — 90.1/91 Homolog of tumor necrosis
factor receptor
Upton et al. (1991);
Shchelkunov et al. (1993a)
D3La 586 C21La 113 — — 99.0/97 Ankyrin-like Shchelkunov et al. (1993b);
Safronov et al. (1996)
C20La 103 — — 67.0/94 —
D3La 586 C19La 259 — — 84.5/233 —
D4La 672 C18La 150 — — 94.3/141 Ankyrin-like Shchelkunov et al. (1993b);
Safronov et al. (1996)
D4La 672 C17La 386 — — 89.7/378 —
D5La 153 C16La 181 D1L 153 96.1/153 94.8/153 Homology to B15R of VAC-
COP (46.2% in 104 aa)
Goebel et al. (1990)
— — C15La 91 — — Ankyrin-like Shchelkunov et al. (1993b)
— — C14L 82 — — —
— — C13L 65 — — —
— — C12L 353 — — Serine protease inhibitor-
like, SPI-1
Turner et al. (1994)
D6L 219 — — — — —
D7L 273 — — — — RCP-like
D8L 661 — — — — Ankyrin-like Safronov et al. (1996)
D9L 75 — — — — Lectin-like
D10L 96 — — — — Lectin-like
D11L 521 — — — — RCP-like
D12L 202 — — — — Homology to C-terminal
domain of poxviral TNF
receptor
D13L 111 — — — — CD30-like
D14L 764 — — — — Ankyrin-like Safronov et al. (1996)
C1L 437 — — — — Ankyrin-like Safronov et al. (1996)
C2L 178 — — — — —
C3L 833 — — — — Ankyrin-like Safronov et al. (1996)
C4L 170 — — D1.5L 128 91.1/123 Homology to C7L of VAC-
COP
C5R 138 C11R 142 D2R 140 90.1/142 85.7/140 Growth factor Blomquist et al. (1984)
C6L 331 C10L 331 D3L 330 98.5/331 97.3/331 —
C7R 242 — — D4R 242 97.9/242 Homology to proteins with
RING zinc finger motif
Senkevich et al. (1994);
Upton et al. (1994)
C8L 124 — — D5L 126 78.9/123 —
C9L 668 — — D6L 452 88.5/462 Ankyrin-like, host range Spehner et al. (1988);
Shchelkunov et al. (1991;
1993b)
— —
C10L 62 — — — — —
C11L 614 C9L 634 — — 69.6/615 Ankyrin-like Shchelkunov et al. (1993b)
D6.5L 91 86.8/91
C11L 614 C9L 634 D7L 153 96.2/130
C12L 182 C8L 184 — — 93.4/181 —
C13L 150 C7L 150 D8L 150 100/150 99.3/150 Host range Chen et al. (1992)
C14L 156 C6L 151 D9L 156 94.0/150 94.9/156 —
C15L 205 C5L 204 — — 97.5/203 RCP-like Xue and Cooley (1993)
C15L 205 C5L 204 D10L 134 90.3/134
C16L 315 C4L 316 D11L 316 99.4/316 95.9/316 —
[ [
438 SHCHELKUNOV ET AL.
TABLE 1—Continued
CPV-GRI VAC-COP VAR-IND
Amino acid identity/
Size of sequence
compared (aa)b
Protein function (homology)c ReferencesORF
Protein
size, (aa) ORF
Protein
size, (aa) ORF
Protein
size, (aa) GRI/COP GRI/IND
C17L 259 C3L 263 D12L 263 95.4/263 91.3/263 Complement-binding protein Kotwal and Moss (1988a);
Kotwal et al. (1990)
C18L 512 C2L 512 — — 99.4/512 RCP-like Xue and Cooley (1993)
D13L 201 92.6/176
C18L 512 C2L 512 D13.5L 79 89.5/86
C19L 231 C1L 224 D14L 214 96.4/225 95.3/214 —
P1L 117 N1L 117 P1L 117 94.9/117 94.9/117 Virulence factor Kotwal et al. (1989)
P2L 175 N2L 175 P2L 177 95.4/175 95.4/175 Putative control of cell
nuclear factor(s) and virus
interaction during the
course of a productive
infection
Tamin et al. (1991)
O1L 474 M1L 472 O1L 446 97.9/474 96.9/447 Ankyrin-like Shchelkunov et al. (1993b)
O2L 163 M2L 220 O2L 220 100/163 96.3/163 —
M1L 284 K1L 284 — — 96.5/284 Ankyrin-like, host range Gillard et al. (1986);
Shchelkunov et al. (1991;
1993b)
O3L 70 90.5/63
M1L 284 K1L 284 C1L 66 95.5/66
M2L 373 K2L 369 C2L 373 97.1/373 95.7/373 Serine protease inhibitor-
like, SPI-3
Law and Smith (1992); Turner
and Moyer (1992); Zhou et
al. (1992)
M3L 88 K3L 88 C3L 88 98.9/88 83.0/88 Interferon resistance Beattie et al. (1991); Davies
et al. (1991)
M4L 424 K4L 424 — — 98.3/424 —
M5L 276 — — — — —
K5L 136 — — 91.7/108 —
M5L 276 K6L 81 — — 94.9/79 —
M6R 161 K7R 149 C4R 149 96.6/149 100/149 —
G1R 238 F1L 226 C5L 251 89.7/234 79.8/252 —
G2R 147 F2L 147 C6L 147 98.0/147 97.3/147 Deoxyuridine
triphosphatase
McGeoch (1990)
G3L 485 F3L 480 C7L 179 97.9/479 93.3/179 RCP-like Xue and Cooley (1993)
G4L 319 F4L 319 C8L 333 98.7/319 97.2/319 Ribonucleotide reductase
small subunit
Slabaugh et al. (1988)
G5L 323 F5L 321 C9L 348 98.5/323 88.6/324 —
G6L 74 F6L 74 C10L 72 100/74 87.3/71 —
G7L 80 F7L 92 C11L 79 85.9/92 82.5/80 —
G8L 65 F8L 65 C12L 65 100/65 96.9/65 —
Right terminal genome region
A51R 334 A51R 334 J5R 334 96.1/334 95.5/334 —
A52R 190 A52R 190 J6R 71 98.4/190 98.5/67 —
A53R 186 A53R 103 — 85.2/54 Homolog of tumor necrosis
factor receptor
Howard et al. (1991)
— A54L 90 — —
A54R 564 A55R 564 J7R 71 98.6/564 90.5/74 RCP-like Xue and Cooley (1993)
A54R 564 A55R 564 J8R 172 80.2/167
A55R 314 A56R 315 J9R 313 95.9/315 84.2/317 EEV envelope and cell
membrane glycoprotein
hemagglutinin, cell–cell
fusion inhibition activity,
and proteolytic activation
of enveloped virus
infectivity interact with the
VAC protein F13
Shida (1986); Jin et al. (1989);
Oie et al. (1990); Seki et al.
(1990); Brown et al. (1991)
[
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TABLE 1—Continued
CPV-GRI VAC-COP VAR-IND
Amino acid identity/
Size of sequence
compared (aa)b
Protein function (homology)c ReferencesORF
Protein
size, (aa) ORF
Protein
size, (aa) ORF
Protein
size, (aa) GRI/COP GRI/IND
A56R 197 A57R 151 J10R 151 97.4/151 95.4/151 Guanylate kinase-like Smith et al. (1991)
B1R 300 B1R 300 B1R 300 99.7/300 96.0/300 Serine/threonine protein
kinase
Traktman et al. (1989); Lin et
al. (1992); Banham and
Smith (1992); Rempel and
Traktman (1992)
B2R 503 B2R 219 — 97.7/215 —
d d B2L 66 —
d d B3L 65 —
B2R 219
B2R 503 B3R 124 — 95.1/123 —
d d B4L 85 —
d d B5L 63 —
B2R 503
B3R 558 B4R 558 B6R 558 96.6/558 95.0/558 Ankyrin-like Smith et al. (1991);
Shchelkunov et al. (1993b)
B4R 317 B5R 317 B7R 317 96.2/317 92.7/316 EEV envelope palmitated
42K glycoprotein needed
for the enveloment of IMV
and EEV formation,
interacts with the VAC
protein F13; a smaller
form of the protein is
secreted from the cell.
Homology to the
complement control
proteins
Isaacs et al. (1992b);
Engelstad et al. (1992);
Wolffe et al. (1993);
Engelstad and Smith (1993);
Martinez-Pomares et al.
(1993)
B5R 183 B6R 173 B8R 56 89.1/183 95.7/46 —
B6R 182 B7R 182 — 97.8/182 —
B7R 271 B8R 272 B9R 266 98.5/268 92.1/266 Secreted from the cell
interferong receptor
homolog
Upton et al. (1992);
Shchelkunov et al. (1993a);
Seregin et al. (1996)
— — B10R 97 —
— — B11R 65 —
B8R 221 B9R 77 — 89.3/75 Homology to T4 protein of
Shope fibroma virus
B9R 501 B10R 166 — 93.8/162 RCP-like Howard et al. (1991)
B10R 105 B11R 88 — 97.7/87 —
B11R 283 B12R 283 B12R 134 98.9/283 80.3/71 Protein kinase-like Banham and Smith (1993)
B12R 345 B13R 116 B13R 344 95.6/114 95.6/344 Serine protease inhibitor-
like, SPI-2. Inhibitor of the
interleukin-1b converting
enzyme, decreases the
level of diHETE in the
cell, virulence factor.
Inhibitor of apoptosis
Pickup et al. (1986); Kotwal
and Moss (1989); Ray et al.
(1992); Palumbo et al.
(1993); Turner et al. (1994);
Dobbelstein and Shenk
(1996)
B12R 345 B14R 222 B13R 344 93.2/221
B13R 149 B15R 149 B14R 149 97.3/149 98.0/149 Homolog of C16L VAC-COP Goebel et al. (1990)
B14R 326 B16R 290 B15R 63 98.3/290 90.2/61 Interleukin-1b binding
protein secreted from the
cell
Spriggs et al. (1992); Alcami
and Smith (1992)
d d B16L 86
B14R 326 B16R 290 B17R 69 88.2/68
B15L 340 B17L 340 B18L 340 98.5/340 95.0/340 —
B16R 574 B18R 574 B19R 574 97.6/574 94.6/574 Ankyrin-like Smith et al. (1991);
Shchelkunov et al. (1993b)
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such repeat, and the number of 54-bp repeats amounts
to 9. With CPV-GRI, this region comprises a number of
altered repeats of 70 and 54 bp (see Fig. 4).
The variability of ITRs is not restricted to differences in
the region of short tandem repeats; the coding sequence
is also subject to complex rearrangements. With CPV-
GRI, five ORFs (D1L–D5L) were identified in this region.
In sharp contrast, the homologous region of VAC-COP,
nine potential ORFs (C23L–C16L) were found. All ORFs in
VAC-COP except C16L are fragments of larger ORFs of
CPV-GRI, while their origin can be traced to numerous
short deletions with a subsequent frame shift (see Table
1, Fig. 2). A similar pattern is observed also with VAC-WR
except that the region corresponding to D4L and D5L in
CPV-GRI is absent in this virus. ITRs of different VAR
strains contain no ORFs.
The ITR regions of VAC-COP and VAC-WR contain
ORFs that are not included in the ITR of CPV-GRI. Such
variations of ITR boundaries can be attributed to recom-
bination processes leading to translocation–inversion of
genome regions adjacent to the ITR. Thus, at the right
terminus of the VAC-WR genome, there is an inverted
duplicate of a fragment from the left genome terminus. It
bears ORFs C6R, C7L, and C8R (ORFs B24R, B25R, and
B26R at the right terminus, see Fig. 3). Translocation also
took place in the VAC-COP genome. Here a segment
TABLE 1—Continued
CPV-GRI VAC-COP VAR-IND
Amino acid identity/
Size of sequence
compared (aa)b
Protein function (homology)c ReferencesORF
Protein
size, (aa) ORF
Protein
size, (aa) ORF
Protein
size, (aa) GRI/COP GRI/IND
B17R 351 B19R 353 B20R 354 92.9/353 90.7/353 Cell surface antigen and
secreted from the cell
glycoprotein. Homology to
the interleukin-1 receptor
Ueda et al. (1990); Morikawa
and Ueda (1993); Symons et
al. (1995)
B18R 795 B20R 127 B21R 787 97.6/125 88.4/795 Ankyrin-like Shchelkunov et al. (1993b)
B19R 557 — B22R 70 82.5/63 RCP-like Shchelkunov et al. (1993d)
B19R 557 — B23R 83 92.7/82
B19R 557 — B24R 88 95.0/80
B20R 375 — B25R 372 91.5/375 Serine protease inhibitor-
like, SPI-1. Homolog of
VAC C12L
Kotwal and Moss (1989);
Smith et al. (1989)
B21R 190 — — Homolog of C13L and C14L
VAC-COP
B22R 1933 — B26R 1896 82.8/
1819
Putative membrane-
associated glycoprotein
Shchelkunov et al. (1994)
K1R 581 B21Ra 91 — 93.2/88 Ankyrin-like, homolog of
C15L VAC-COP
Shchelkunov et al. (1993b)
K2R 322 — — Homolog of tumor necrosis
factor receptor
K3R 167 — — Homolog of tumor necrosis
factor receptor
S1R 210 — — —
H1Ra 153 B22Ra 181 — 96.1/153 Homolog of C16L VAC-COP
H2Ra 672 B23Ra 386 — 89.7/378 Ankyrin-like Shchelkunov et al. (1993b)
H2Ra 672 B24Ra 150 — 94.3/141 —
H3Ra 586 B25Ra 259 G1R 585 84.5/233 90.9/584 Ankyrin-like Shchelkunov et al. (1993b)
H3Ra 586 B26Ra 103 G1R 585 67.0/94 —
H3Ra 586 B27Ra 113 G1R 585 99.0/97 —
H4Ra 351 B28Ra 122 G2R 349 90.1/91 90.9/351 Homolog of tumor necrosis
factor receptor
Howard et al. (1991)
H5Ra 255 B28.5Ra 57 G3R 253 92.3/13 Most abundant protein
secreted from the cell
Patel et al. (1990); Martinez-
Pomares et al. (1995)
H5Ra 255 B29Ra 244 G3R 253 97.1/242 92.9/255
Note. A dash indicates a deletion in the coding sequence of one virus relative to the other.
a ORFs from the inverted terminal repeats of the viral genomes.
b Values of amino acid sequence identity (in percentages) are presented and calculated by FASTA analysis (Pearson and Lipman, 1988).
c Experimentally revealed functions of viral proteins or functions clarified due to homology with sequences of the known cellular proteins (in these
cases, written ‘‘like’’) are indicated. Lack of such data is denoted by a dash.
d Regions where the potential ORFs without homology to the others due to the mutational changes in DNA of one virus relative to the other.
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from the right genome terminus of an ancestral virus had
been translocated to the left end. The translocated frag-
ment coding for VAC-COP ORFs C15L–C12L (Fig. 2) cor-
responds to two regions of the right terminus of the
CPV-GRI genome: B20R-B21R (homologs of VAC-COP
C12L–C14L) and the 59-terminal region of K1R (homolog
of VAC-COP C15L) (Fig. 3 and Table 1). It is noteworthy
that homologs of VAC-COP C15L and C14L–C12L in the
right terminus of the CPV-GRI genome are separated by
a sequence of 5.6 kbp. This suggests that a longer
fragment (for example, the fragment between B20R and
S1R according to the CPV-GRI genome) was initially
translocated from the right genomic terminus of the an-
cestor virus to the left, therefore considerably increasing
the size of the ITR region. Subsequent deletions resulted
in the loss of various regions of the translocated frag-
ment within different termini; in this process, the VAC-
COP ITR proved to be increased only in the region of
C15L ORF.
It should be noted that such rearrangements are a
rather frequent phenomenon with orthopoxviruses (Moyer
et al., 1980a,b; Moyer and Graves, 1982; Pickup et al.,
1984; Kotwal and Moss, 1988b).
Nonrepeating sequences
In the CPV-GRI genome at the left terminus adjacent to
the ITR, a sequence of 14,171 bp begins that encodes 12
potential ORFs (from D6L to C3L). This is unique, since
neither VAC or VAR have a corresponding region (Fig. 2).
In addition, the left terminus of the CPV genome contains
all DNA sequences that previously were considered
unique only to certain strains of VAC and VAR. An excep-
tion to this is the occurrence of a C15L–C12L region of
VAC-COP which was translocated from the right terminus
(see above). Comparative analysis showed that many
homologs of CPV ORFs are either very abridged or ter-
minated to several shorter ORFs in different strains of
VAC and VAR (see Table 1, Fig. 2). A similar situation is
observed in the right part of the CPV-GRI genome. The
sequences of 1579 and 3585 bp, unique to CPV, located
there (Fig. 3) include ORFs B8R and B9R and K1R–K3R,
S1R, respectively. The CPV-GRI ORFs B2R, B19R, B21R,
and H2R are either split or deleted in the case of VAR and
VAC (Fig. 3). These data provide evidence that in terms of
evolution, CPV stands far closer to an ancestor virus than
do any of the other orthopoxviruses.
Comparative analysis of the right terminal regions of
orthopoxvirus genomes allowed us also to suggest a
VAR-specific DNA segment 2068 bp long containing
ORFs B10R and B11R of VAR-IND or H10R–H12R of VAR-
GAR. This was absent in DNA of the CPV and VAC strains
(Fig. 3). As we described earlier (Massung et al., 1996),
the region of 627 bp that is specific for alastrim (variola
minor) virus strains is located in this segment.
Comparison of CPV-GRI ORF C11L coding for an
ankyrin-like protein (Safronov et al., 1996) with the cor-
responding VAC-COP ORF C9L (or C15L of VAC-WR) gave
an unexpectedly low homology, found to be only 69%.
This is the lowest value obtained when comparing all
sequenced regions of VAC and CPV DNA. However, the
extent of similarity between CPV-GRI protein C11L and
the corresponding short VAR ORFs (Table 1) does not
FIG. 4. The pattern of the alternation of tandem repeats within the ITR region of different orthopoxviruses (VAC-COP, VAC-WR, CPV-GRI, CPV-BRI,
VAR-BSH, VAR-GAR). White squares indicate the nonrepeating sequences of ITR: NRI and NRII and the encoding region. The black blocks correspond
to the tandem repeats with a size of 70 bp. The characters above them indicate the repeat numbers in the first and second tandems. The gray blocks
indicate the 54-bp repeats, while their ordinal indexes are given under the blocks. The pentagons in the ITR sequence of VAC-COP and VAC-WR
indicate the 125-bp repeats. Repeats differing from the consensus sequence (deletions, substitutions, inserts) are marked with asterisks. The black
circle indicates the terminal hairpin. The circumference and black sector within it indicate that the hairpin nucleotide sequence was not identified or
only incompletely identified. Deletions within the DNA sequence are dotted.
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differ from the average homology level of the other CPV
and VAR ORFs. Our comparative analysis study of the
identity of the nucleic acids in these genomic segments
of various orthopoxvirus species (Fig. 5) suggests that
this VAC gene has undergone unusually large changes,
most likely as a result of recombination with either an
unknown representative of the orthopoxvirus family or
with the sequence of a cellular gene after the process of
retrotransposition. Comparing VAC-COP and VAC-WR
one can conclude that the revealed difference is spe-
cies-specific for vaccinia virus. In this regard, the com-
parative study of this protein in VAC and CPV is of great
importance.
The data obtained suggest that CPV has the most
ancient ‘‘native’’ genome when compared with the human
pathogenic species of orthopoxviruses, such as VAR and
VAC. Therefore, VAR and VAC may be considered as
variants that originated from CPV or from a CPV-like virus
as a result of deletions and mutations which damaged
and changed certain genes of the ancestor virus. How-
ever, the evolution of orthopoxviruses is unlikely to be
confined to mutational changes only. As indicated above,
the specific insertion point in the right terminal genomic
region of VAR and the specific substitution of the gene for
ankyrin-like protein for the gene of the same family, but
with considerable differences in its nucleotide and
amino acid sequences, was found in the left terminal
region of VAC.
A very high proportion of identity in the ORFs is re-
vealed among strains belonging to one and the same
species of orthopoxviruses (VAC or VAR). Many proteins
differ in the substitution of only a single amino acid. A
different pattern is observed, however, when we com-
pare common genes of cowpox virus, strain Brighton
(CPV-BRI) (Pickup et al., 1982; Spehner et al., 1988; Hu et
al., 1994), with sequences of CPV-GRI ORFs. Thus, the
homologs of proteins CPV-GRI D1L (ORF B CPV-BRI),
D2L (crmB in CPV-BRI), A53R (crmC in CPV-BRI), B12R
(crmA in CPV-BRI), and C9L (CHO hr in CPV-BRI) in
CPV-BRI have similar sizes but their identity rate is 82–
92%, i.e., comparable to or even lower than that estab-
lished in comparing CPV-GRI with the strains of VAC and
VAR (see Table 1). This may be proof in favor of high
heterogeneity of CPV strains circulating in nature in var-
ious geographic regions. Another possible explanation
for the differences observed is that CPV-BRI is an old
laboratory strain (Downie, 1939; Fenner, 1958). The long
history of passaging may explain the accumulation of
numerous mutations. It is also possible that the muta-
tions do not significantly alter the function and therefore
there is less pressure to conserve.
It should be noted that, for VAC, it was experimentally
proved that practically all genes of the left and right ends
of the genome are not essential for viral propagation in
cell culture (Perkus et al., 1991; Shchelkunov, 1995). Ap-
parently, they influence such functions as host range
determination, tissue tropism, interaction with several
cellular factors, and host defense systems. Information
on proposed functions of the proteins is given in Table 1.
With respect to the properties of the proteins being
encoded by the variable regions of the CPV genome
under study, they can be subdivided into four main
FIG. 5. Analysis of the DNA nucleotide sequence identity of the CPV-GRI gene C11L region for the pairs CPV-GRI/VAC-WR and CPV-GRI/VAR-GAR.
The identity level of the compared sequences is shown graphically at the top; genetic maps of the analyzed genomic regions of the viruses are at
the bottom. The gray vertical block indicates the area of small deletions in the VAR-GAR genome.
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groups: growth factors/immunomodulatory proteins, the
tumor necrosis factor receptor family, host range factors,
and the ring canal protein (RCP) family.
Growth factors and immunomodulatory proteins
The sequence analysis of orthopoxviruses has shed
light on the ability of VAR to cause a generalized and
often fatal infection. This pathogenesis of VAR can be
attributed to numerous gene products. Previously, we
compared VAR genes with those of VAC, which were
presumably producing a pathogenic effect in this infec-
tion, and proposed that the differences in certain genes
might determine the virulence characteristics of these
viruses (Shchelkunov, 1995; Shchelkunov et al., 1993a,
1994, 1996). Genes of this type are located at both the left
and the right variable termini of orthopoxviral genomes.
The orthopoxviral genomes encode for a protein VGF,
which shows the highest homology to the epidermal
growth factor (EGF) and transforming growth factor (TGF)
(Blomquist et al., 1984; Brown et al., 1985; Buller et al.,
1988a; Massague and Pandiella, 1993). This protein was
demonstrated to be a growth factor in the chorioallantoic
membrane of chicken embryos (Buller et al., 1988b). Its
corresponding CPV gene is C5R, in CPV-GRI. A gene
encoding the EGF-like protein was also found in other
poxviruses such as myxoma virus, Shope fibroma virus,
and malignant fibroma virus in rabbits (Upton et al., 1987,
1988; Opgenorth et al., 1993). Comparison of C5R with
VGF of VAR and VAC revealed multiple differences (Fig. 6)
that were mainly found at the N-terminus of the protein
being formed by cleaving off the signal peptide. It is not
yet clear whether these differences can bring about
qualitative changes in the protein’s function. It is known,
however, that substitution of myxoma virus growth factor
gene with the TGF gene of rats, VGF, or Shope fibroma
virus growth factor provides for restoration of myxoma
virus pathogenic properties (Opgenorth et al., 1993). The
latter virus has a far lower effect than does the orthopox-
virus EGF.
It was demonstrated that ectromelia virus p28 pro-
tein plays an important role in manifestation of viru-
lence properties of this mouse poxvirus (Senkevich et
al., 1994). High homology to this protein is found in
proteins C7R CPV-GRI, D4R VAR-IND, and B5R VAR-
GAR. The gene of this protein is completely deleted in
VAC-COP, and in VAC-WR it lacks 58 C-terminal amino
acid residues. The C-terminal domain, containing the
C3HC4 motif, is essential for the binding of zinc cat-
ions. This binding is probably to DNA. The presence of
this motif demonstrates that these proteins belong to
the protein family containing the zinc finger sequence
of human gene RING1 and participates in gene ex-
pression, regulation, replication, and recombination of
the DNA molecules (Freemont et al., 1991; Lovering et
al., 1993; Upton et al., 1994). The protein under study is
believed to play an important role in regulation of virus
propagation in vivo (Senkevich et al., 1994). The pres-
ence of highly conserved analogs of this protein in
VAR, CPV, ECT, and VAC strain IHD-W (Upton et al.,
1994) provides evidence that the analogs are not the
main cause of such sharp differences between these
viruses in terms of their pathogenic properties.
It is known that many poxvirus-encoded proteins are
secreted from infected cells and referred to as virokines
(Kotwal and Moss, 1988a). Virokines play an important
role in interacting with the immune system (Kotwal, 1996,
1997). In this context a protein which is very interesting
and encoded by CPV-GRI within the left end (and also the
right end) is the gene D1L (H5R). For VAC strain Lister, it
was proved (Patel et al., 1990) that this gene is directing
the synthesis and secretion of large amounts of a 35-kDa
protein within the entire cycle of virus propagation. It was
shown that in rabbit poxvirus, a defect in this gene under
certain conditions affects viral virulence (Martinez-Po-
mares et al., 1995). With sublethal doses of intranasal
infection in mice, the wild-type virus was more patho-
genic than a mutant. With higher doses of infection, no
differences in virulence between the wild-type and mu-
FIG. 6. Alignment of amino acid sequences of proteins belonging to the epidermal growth factor family. The gray vertical blocks indicate the
conservative cysteine residues. The links between the cysteine residues in the protein molecules are superscribed with the square brackets.
Hydrophobic, transmembrane protein segments are framed. Mature forms of VAC proteins being formed by splitting off the N- and C-terminal domains
are bounded by vertical lines.
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tant virus were observed. Recently, a homolog of the
gene T1/35 kDa in myxoma virus was shown to bind
chemokines and to modulate leukocyte influx into virus-
infected tissue (Graham et al., 1997). Different VAR
strains contain a nondeficient homologous gene of D1L
CPV-GRI, only as one copy in the right terminus of ge-
nome (Fig. 3; Table 1; Shchelkunov et al., 1994; Massung
et al., 1994, 1996). In the case of VAC-WR and VAC-COP,
the homolog of this gene is represented by two overlap-
ping ORFs (Figs. 2 and 3). Protein 7.5 kDa is encoded by
a short ORF (C2L in VAC-WR) and has a size of only 57
aa, while the region of homology to D1L CPV-GRI and
G3R VAR covers only the first 11 aa of the signal peptide.
Potential ORFs C23L in VAC-COP and C1L in VAC-WR
encode the major part of the 35-kDa protein. This reveals
high homology to similar ORFs of other orthopoxviruses.
However, the absence of signal peptide and close ar-
rangement of the start ATG codons of the two neighbor-
ing overlapping ORFs makes the secretion as well as the
synthesis of this protein in both VAC-COP and VAC-WR
highly unlikely. Thus, VAC-WR was demonstrated to have
no secretion of a 35-kDa protein similar to that found in
the VAC strain Lister (Patel et al., 1990).
An important contribution to VAC virulence in an intra-
cranial LD50 model is made by another secretory protein
encoded by the N1L gene (VAC-WR) (Kotwal et al., 1989).
The function of this protein still remains enigmatic. It
should be noted that there are very slight differences in
the sequence of this protein when comparing CPV, VAR,
and VAC (Table 1). Thus, this protein might prove to be
involved in interaction with the host.
Among the first immunomodulatory proteins, the vac-
cinia virus complement control protein VCP was the first
discovered among orthopoxviruses (Kotwal and Moss,
1988a; Kotwal et al., 1990; Isaacs et al., 1992a); it was
shown to inhibit both the complement-mediated lysis of
infected cells and virus neutralization. The VCP of or-
thopoxviruses contains four repeating domains (approx.
60 aa and referred to as short consensus repeats, SCRs)
found typically in complement-control proteins. These
domains bear four conservative cysteine residues (Fig.
7). Their number and arrangement remained unchanged
in IMP of CPV and in homologs found in VAC and VAR.
This allows an assumption that the secondary structure
of these proteins is critical. It is interesting that in the first
domain of CPV-GRI VCP (C17L), between the first and
second cysteine residues in the first repeat, a small
deletion was discovered as well as numerous differ-
ences from corresponding proteins of VAC and VAR hav-
ing high homology in this region. Surprisingly, the Brigh-
ton strain of CPV seems more similar to VAC and VAR in
this region than does the CPV-GRI (Howard and Kotwal,
unpublished). Sequences of CPV and VAC proteins, in
the area from the second to the fourth domain, differ in 1
amino acid only. The identity rate of VCP of VAR and VAC
does not significantly differ from data established for
other proteins, though among 12 amino acid differences
between VAC and VAR, 9 are substitution of neutral
amino acid by charged ones or charged ones by neutral
amino acids (Fig. 7). CPV-GRI, in this region, is almost
identical to VAC (one difference). It is possible that these
differences may influence the affinity of viral protein
binding with the components of the complement system.
Perhaps VCP has some species-specific differences.
Since both in vitro anti-complement activity and in vivo
anti-inflammatory activity was found, the homolog of VCP
in CPV was named the inflammation modulatory protein
(IMP) (Miller et al., 1997). The sequence of the IMP of the
Brighton strain of CPV indicates that it has a 92% identity
to the CPV-GRI strain at the nucleotide level and 96% at
the amino acid level (Howard and Kotwal, unpublished).
The high resistance of orthopoxviruses to interferon is
determined by several genes; one of them (K3L VAC-
COP) is located in the left terminal end of the genome. A
mutant VAC lacking the ORF for K3L becomes sensitive
to interferon so that virus titers decrease by 2 orders
(Beattie et al., 1991). The VAC K3L gene was found to
encode a protein (Beattie et al., 1991; Davies et al., 1991,
1993) homologous to the N-terminal region of the elF-2a
which contains a site for serine phosphorylation. This
protein was shown to inhibit, in vivo, the elF-2a phos-
phorylation by DAI kinase (Davies et al., 1991). The CPV-
GRI isolog M3L is highly identical to VAC-COP K3L.
However, analogous VAR-IND protein (C3L) differs con-
siderably from the VAC-COP K3L protein (see Table 1),
although it is identical as regards both VAR-IND and
VAR-BSH (Shchelkunov et al., 1995, 1996). When compar-
ing the K3L ORFs of VAC-COP and VAC-WR, only a single
amino acid substitution was found. Thus, the viral elF-2a
homolog is highly conserved for CPV and VAC but shows
multiple differences between VAR and VAC. Evidently,
these differences have an effect on the secondary
structure of the protein (Shchelkunov et al., 1996) and
may influence the pathogenic properties of VAR and
CPV (VAC).
Orthopoxviruses utilize other mechanisms of resis-
tance to interferon action by synthesizing various types
of interferon receptors which are secreted from the cells.
VAC was demonstrated to produce the soluble receptor
for type I interferons (IFNa and IFNb) encoded by
VAC-WR gene B18R (B19R of VAC-COP) (Symons et al.,
1995). Comparative analysis of the amino acid sequence
of this protein among various strains (Fig. 8) demon-
strated a high degree of similarity within one species and
multiple dissimilarities between different orthopoxvirus
species; these differences are likely to determine the
species-specific characteristics and other properties of
this viral protein.
The soluble receptor of IFNg encoded by CPV-GRI
gene B7R is highly homologous to the corresponding
protein of VAC-COP; these have a number of distinctions
from the VAR-IND isolog (Table 1).
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The other virulence factor, hemagglutinin, exhibits a
high identity between CPV-GRI (A55R) and VAC-COP
(A56R); however, it differs considerably from that of
VAR-IND in both its primary and secondary structures
(Shchelkunov et al., 1994).
Finding of homologs in the data bank do not always
lead to a clear conclusion about the biological function of
a protein under study. It does help in some cases to
indicate certain potential properties of a given protein.
Thus, for example, two neighboring ORFs, D9L and D10L
CPV-GRI, reveal an average homology of 20–30% with
quite a number of proteins containing a C-type lectin
domain. In terms of function, all of these proteins can be
related to proteins being expressed on cellular mem-
branes. These are involved in intercellular interaction:
human B-cell differentiation antigen (CD72); low-affinity
Fc receptors of murine and human IgE that are also
participating in B-cell differentiation; lectin-like proteins,
etc. It should be noted that D10L has homology to the
N-terminus of the lectin domain and D9L to the C-termi-
nus of that domain. Possibly these two potential ORFs of
CPV-GRI arose as a result of fragmentation of a single
gene of the ancestor virus. Perhaps this viral protein was
capable of introducing changes to interact with immune
cells as immune and/or inflammatory virus-induced re-
sponse was evolving.
FIG. 7. Alignment of amino acid sequences of orthopoxviral proteins homologous to the complement binding proteins family. ORFs of CPV, VAR,
and VAC are shown. The conservative cysteine residues are marked with gray vertical blocks. The digits above the blocks indicate four repeating
domains typical of the complement-controlling proteins. The circles marked ‘‘plus’’ or ‘‘minus’’ indicate those amino acid residues within the protein
sequence of VAC (top view) and VAR (bottom view) that differ in charge. The coinciding amino acid residues in the proteins analyzed, relative to C3L
VAC-COP, are marked with dots; amino acid deletions are marked with dashes.
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Tumor necrosis factor receptor family
Polypeptide ligands and their receptors are found to
coevolve (Murphy, 1993). Pathogenic microorganisms
are thought to cause an accelerated evolution of the
genes of the defense system during infection. Such evo-
lutionary changes of the primary structure of the proteins
constituting ligand–receptor pairs were suggested to re-
sult in alterations of the quaternary structure of the li-
gand–receptor contact region (Murphy, 1993; Beutler and
van Huffel, 1994). As a result, the species-specific mim-
icry of the mammalian defense system proteins may
emerge, providing a narrowed range of hosts suscepti-
ble to certain infectious microorganisms (Murphy, 1993).
Recent data demonstrate that cytokines and their spe-
cific receptors undergo considerable structural alteration
during the course of evolution. Such alterations may
occur relatively rapidly on the evolutionary scale. Thus,
mouse IFNg does interact (although not strongly) with
human IFNg receptor and vice versa. On the other hand,
this cytokine binds to its receptor with a high efficiency
within the species (Beutler and van Huffel, 1994). Now it
is evident that any cytokine can function only if its recep-
tor is located on the plasma membrane. This question of
coevolution of cytokines and their receptors and, on a
more global scale, of various receptor–ligand pairs, is of
great current interest.
FIG. 8. Alignment of the amino acid sequences of viral soluble interferon type I receptor encoded by the corresponding genes of CPV-GRI, VAC-COP,
VAC-WR, VAR-IND, and VAR-GAR. The gray vertical blocks indicate the conservative cysteine residues. The coinciding amino acid residues in the
proteins analyzed relative to B17R CPV-GRI are marked with dots; amino acid deletions are marked with dashes.
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Protein families similar to tumor necrosis factor (TNF)
(Tracey and Cerami, 1994) and its receptor (Smith et al.,
1994) attract considerable current interest. It is sug-
gested that a complex network of TNF-like receptor–
ligand pairs, which performs protective functions in the
animal, had formed during evolution as a result of dupli-
cations and subsequent modifications of ancestor genes
of a receptor and its ligand (Beutler and van Huffel, 1994).
Deletion of the genes for TNF and IFNg, the most well-
studied cytokines, or the genes for their receptors was
demonstrated to increase considerably the sensitivity of
animals to pathogenic action of such intracellular para-
sites as Listeria, mycobacteria, and viruses (Havell, 1989;
Pfeffer et al., 1993; Flynn et al., 1993; Huang et al., 1993).
TNF-like proteins and/or their receptors may perform
partially overlapping functions, therefore making possi-
ble the relative stability of such multicompetent molecu-
lar systems and the possibility of fine-tuned regulation
(Beutler and van Huffel, 1994).
Studies on the interaction network of cytokines and
their receptors is in early stages; much work still needs
to be done. Orthopoxviruses provide an important model
system here. The genes encoding cell-secreted (soluble)
receptors for TNF, IFNg, IFNab, and interleukin-1b (IL-
1b) were first discovered in these viruses. In addition,
orthopoxviruses are capable of inhibiting a number of
endogenous cytokines of the host organism. The differ-
ent species of orthopoxviruses vary in the set of genes
coding for secretory cytokine receptors (or viroceptors).
Thus, variola virus encodes receptors for TNF, IFNg, and
IFNab while vaccinia virus encodes receptors for IFNg,
IFNab, and IL-1b. Moreover, some of these viroceptors
possess marked specific activity only toward the ligands
of the animal species in which the virus is propagating,
whereas other receptors do not exhibit such properties
(Alcami and Smith, 1992).
Investigation of the genetic organization of cowpox
virus is of special interest from this standpoint, since this
species has the widest host range among the poxvi-
ruses, i.e., is able to multiply in different molecular envi-
ronments and is able to overcome protective mecha-
nisms of various mammalian species. Computer analysis
of the sequencing data allowed us to identify the genes
for IFNg, IFNab, and IL-1b receptors in the genome of
CPV-GRI. Unexpected results were found while analyzing
the CPV-GRI genes coding for proteins of the TNF recep-
tor family. This virus appeared to have five different
proteins of this family, the characteristics of which were
relatively high homology in some instances together with
pronounced distinctions in others (Fig. 9, Table 2).
TNF cell receptors types I and II belong to a super-
family of the membrane-associated proteins and consist
of four extracellular domains, which are rich in cysteines.
They are located at the N-terminus of the protein and are
responsible for binding with TNF. They occur in the
hydrophobic transmembrane region and in the cytoplas-
mic domain. Viral receptors of TNF also contain four
cysteine-rich domains homologous to cellular analogs
(Shchelkunov et al., 1994). With the exception of the
C-terminal domain, they have no homology to sequences
of the TNF cellular receptors, nor to any other known
proteins (Smith and Goodwin, 1994).
Comparison of the three orthopoxvirus species (Fig.
10) demonstrated that vaccinia virus contained only two
mutation-disrupted genes of this family in its genome;
one of them was duplicated (C22L and B28R) as a part of
terminal inverted repeats, i.e., VAC was not capable of
synthesizing this type of protein. Variola virus contains
the only gene of the family under consideration and is
likely to synthesize a fully functional secretory protein
which would bind human TNF.
The unexpectedly large set of ORFs of the TNF recep-
tor family within the CPV genome demonstrates how little
we know about the network of the mammalian TNF-like
receptors and ligands. Since nonfunctional viral genes
are eliminated in the evolutionary process, we may con-
clude that each of the TNF receptor homologs contained
in the CPV genome must have its specific protein li-
gand(s) in the host organism, which most likely belongs
to the family of TNF homologs. For example, CPV-GRI
protein D13L exhibits maximal homology to the receptor
part of cellular protein CD30, which belongs to the su-
perfamily of TNF receptor proteins. This protein most
likely blocks the CD30L-mediated interaction of mono-
cytes and lymphocytes and consequently hinders the
development of both cell-mediated and humoral immune
responses to viral infection. It is of interest that the
potential ORF D12L encoding the C-terminal domain of
orthopoxviral TNF receptors is adjacent to ORF D13L
(Fig. 9) (Smith and Goodwin, 1994). It is likely that the
frames D13L and D12L originated through mutational
splitting of the single preexisting ORF.
CPV protein D2L (H4R) is highly homologous to the TNF
type II receptor and is likely to play an important role in
aiding the virus to evade the response from the host’s
defense systems. (Shchelkunov et al., 1993a). We found an
absence of such an apparent homology of the other CPV-
GRI proteins belonging to the TNF receptor family to all
proteins available in the protein databases. It most likely
indicates that the ligands of the new CPV receptor proteins
have not yet been discovered. Research in this direction
will allow deeper insight into the organization of the net-
work of TNF-like ligands and receptors, including those of
humans. The situation that different CPV proteins from the
family under consideration selectively exhibit their activity
in different animal species might be expected to allow
expansion of the host range of this virus.
The viral TNF receptor is known to function in a form
of a dimer which shows a greater affinity for TNF (Smith
and Goodwin, 1994). The assumption that viral analogs
of TNF receptor are capable of forming receptor mole-
cules consisting of the subunits of different viral proteins
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implies a considerable evolutionary expansion of the
possibilities of cowpox virus to produce numerous com-
binations of such receptors and thus broaden the viral
host range.
The question of whether all the discovered CPV
ORFs of the family under consideration are of cellular
origin (for example, they all have been integrated into
the viral genome through retrotransposition) or instead
originated through duplications of a single ancestor
viral gene with subsequent evolutionary divergence is
unanswered. As we can see, the CPV genome is of
unique interest since it encodes a wider set of poten-
tial virulence factors than VAR or VAC. The fact that an
increased virulence is not characteristic of CPV sug-
gests the existence of a regulatory system in orthopox-
viruses that controls pathogenesis. Earlier we intro-
duced the notion of ‘‘buffer genes’’ of orthopoxviruses
(Shchelkunov, 1995); their role is to neutralize the
negative effects that develop in the infected host.
Cowpox virus is likely to possess the widest set of
such genes, when compared with VAR or VAC.
TABLE 2
ORFs of Cowpox Virus GRI-90 Belonging to the Tumor Necrosis
Factor Receptor Family
ORF
Size
(aa)
Percentage of identity
D2L D13L A53R K2R K3R
D2L/H3R 351 21 31 49 44
D13L 111 21 19 23 26
A53R 186 31 19 32 35
K2R 322 49 23 32 41
K3R 167 44 26 35 41
FIG. 9. Alignment of the amino acid sequences of potential CPV-GRI ORFs encoding proteins of the tumor necrosis factor (TNF) receptor family.
The conservative cysteine residues are marked with gray vertical blocks. The digits above the blocks indicate four domains typical of the TNF
receptor-like proteins. The coinciding amino acid residues in the proteins analyzed relative to D2L CPV-GRI are marked with dots; amino acid
deletions are marked with dashes. The C-termini of amino acid sequences are noted by asterisks.
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The largest orthopoxviral protein
While analyzing the nucleotide sequence of VAR-IND
genome, we discovered a potential ORF, B26R, encoding
for the largest orthopoxviral protein (Shchelkunov
et al., 1993d). The organization of 59- and 39-terminal re-
gions of this gene suggests it to be an early gene. This
protein exhibits pronounced characteristics of a mem-
brane-associated type III glycoprotein. However, the pro-
tein’s function and location are unknown. Hybridization
(Shchelkunov et al., 1994) and PCR analyses (Massung
et al., 1994) demonstrated that the region of this gene is
absent in the genomes of vaccinia, buffalopox, and rab-
bitpox viruses, whereas it is present in the genomes of
monkeypox, cowpox, camelpox, and ectromelia viruses.
Comparison of various VAR strains (Shchelkunov et al.,
1995; Massung et al., 1996) demonstrated that this pro-
tein is highly conserved. Hence, the numerous differ-
ences of the analogous CPV-GRI ORF B22R from the
corresponding VAR ORF (Fig. 11) was quite unexpected.
Membrane-associated glycoproteins in general often es-
tablish the species-specific properties of viruses.
Host range genes and their homologs
Significant variations are being observed with respect
to the host range of certain species of orthopoxviruses.
Thus, CPV has a wide host range, being isolated from a
variety of animal species consisting of 9 of 18 orders of
the mammalian class (Marennikova et al., 1984). VAC is
capable of propagating in different animal species,
though its natural host has not yet been identified. VAR is
anthropotrophic, i.e., its only host is man. In this aspect,
ectromelia virus (ECT) is similar, but even more selective
since it can propagate only in certain stains of laboratory
mice. (Fenner et al., 1989).
This monotropic nature of orthopoxviruses provides an
excellent model for identification of, and studies on, virus
genes responsible for host range determination (hr
genes). Unfortunately, genes leading to changes in the
host range of sensitive animals have not yet been iden-
tified. However, at least three genes of orthopoxviruses
have been identified for host range in cell cultures (Chen
et al., 1992).
All three hr genes are located in the left variable part
of orthopoxvirus genome (Shchelkunov et al., 1996). In
the CPV-GRI genome, these are C9L, C13L, and M1L.
The most conserved of them is C13L; it is identical to
genes C7L VAC-COP (Chen et al., 1992) and C17L
VAC-WR (Kotwal and Moss, 1988b), but differs from VAR
homolog genes by the substitution of a single amino
acid. Probably an important function determines this
gene change.
A relatively high homology rate to C13L CPV-GRI
nearly throughout its length is revealed by ORF C4L
CPV-GRI (30.6% in 147 aa). In the VAC genome, this gene
is absent. In VAR, it is found to be considerably reduced
due to deletion of the N-terminal region of ORF. Appar-
ently, the product of this potential VAR ORF, beginning
with the alternative ATG codon, is not synthesized at all.
Data of the analysis performed allow an assumption that
C4L CPV may be the gene responsible for host range
determination.
The other two hr genes are less conserved than C13L.
With VAR, the homolog of M1L CPV-GRI involves two
shorter ORFs, while with VAC this gene (K1L VAC-COP) is
identical in size and has a relatively high homology to
M1L in CPV. It was demonstrated that elimination of this
gene resulted in VAC losing its ability to replicate in
rabbit kidney (RK13) cell culture (Perkus et al., 1990;
Gillard et al., 1986).
A full-size gene, C9L, was found only in CPV-GRI and
CPV-BRI genomes. In this region of the VAC-COP ge-
nome there is an extended deletion. In the case of
VAC-WR and ectromelia virus, strain Moscow (ECT-
MOS), the ORF under study is mutation-divided into four
and five shorter potential ORFs, respectively (Fig. 12). A
similar pattern is observed for ECT strains Hamstead
and Mill Hill (Chen et al., 1992). In the case of VAR-IND,
in the respective ORF 207 aa encoding the C-terminal
region are deleted. In VAR-GAR, two short ORFs were
established (Massung et al., 1996) which corresponded
to the N-terminal region of C9L CPV-GRI. It was demon-
strated that this CPV gene, termed CHO hr, encodes a
protein of 77 kDa (Spehner et al., 1988). After this gene
integrates into the VAC genome the virus acquires the
FIG. 10. Graphic representation of location of the ORFs encoding the viral proteins of the tumor necrosis factor receptor family. Arrows indicate the
direction and size of the corresponding ORFs of CPV-GRI, VAC-COP, and VAR-IND viruses. ORF designations are shown above the arrows. The black
blocks indicate the DNA sequences of the viral DNAs. Deletions in DNA of one virus relative to others are marked by a thin line.
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ability to propagate in CHO cells. It still remains unknown
whether a reduced variant of the CHO hr gene in VAR has
any biological function.
A specific function of the hr genes has not yet been
established clearly, but it has been demonstrated that
the CHO hr gene product precludes the blocking of
translation of viral intermediate mRNAs in CHO cells,
thus providing for expression of late viral genes (Ram-
sey-Ewing and Moss, 1995). Gene K1L VAC-COP induces
synthesis in the RK13 cells of cellular factor VITF-2 which
is essential to transcription of intermediate genes of the
virus (Rosales et al., 1994). It should be noted that in cells
permissive to VAC K1L2, VITF-2 is also synthesized even
in the absence of viral infection.
An important feature of proteins CHO hr (C9L) and
M1L of CPV-GRI is that they belong to the ankyrin-like
protein family (Shchelkunov et al., 1993b; Safronov et al.,
1996) which functions in interaction with the integral
membrane proteins and cytoskeleton elements (Lux et
al., 1990). This is the most numerous family of orthopox-
virus proteins, being encoded exclusively in the left and
right variable ends of the genome. Thus, in the left and
right ends of the CPV-GRI genome, 10 and 6 genes,
respectively, from this family have been identified. It is
interesting that in the VAR and VAC genomes most of
these genes are either absent or represented by their
reduced fragments (see Table 1, Fig. 13). At the left
terminus of the VAR genome, encoding for only one
full-size analog of CPV ankyrin-like protein was found,
and three such genes were established with VAC. Only
four of the six ankyrin-like CPV genes were retained in
the right terminal region of the VAR genome. Only 2
genes are highly identical to the corresponding CPV
genes in the two studied VAC strains; the rest have been
either disrupted or deleted through mutations (Fig. 13).
Analysis of amino acid sequences of ankyrin-like pro-
teins of the three orthopoxvirus species revealed differ-
ent numbers of so-called ankyrin repeats characteristic
of the proteins of this family. This was true for each of the
proteins (Fig. 13). A comparison of 54 such repeats in
these viral proteins allowed us to define the conservative
sequences in this repeat (Fig. 14).
In most conserved regions of the ankyrin repeat, amino
acid residues (from 4th to 10th and from 20th to 25th) are
assumed to create a-helical structures (Lux et al., 1990)
which interact in an anti-parallel direction. This is due to
hydrophobic interaction of amino acids, located at one side
of each a helix (positions 6, 10, and 21, 25, respectively). The
regions between these conservative blocks in the different
repeats, vary in the number of amino acids and can be
characterized as having an increased level of polar and
charged amino acids (Fig. 14). Each of the compared CPV
proteins has its own characteristic ‘‘topography’’ of location
of ankyrin repeats (Safronov et al., 1996).
A unique characteristic of CPV is also the fact that this
virus has not only the widest host range among the
orthopoxviruses but the widest set of the genes coding
for the proteins with multiple ankyrin repeats. We pro-
pose that deletion or mutational disruption of these
genes may result in narrowing of the range of the ani-
mals permissive to this virus; however, this assumption
requires experimental substantiation.
The identity rate of different ankyrin-like proteins from
the orthopoxvirus family within the regions bearing tan-
dems of ankyrin repeats is approx. 25%. Besides, these
proteins contain rather extended domains with a very
high homology, for example, CPV-D14L/CPV-C3L: 45% in
589 aa; CPV-D8L/CPV-B16R: 57% in 386 aa. The rather
moderate homology level of the hr genes and other
genes from ankyrin-like protein families, though giving
no guarantee of the identity of their biological functions,
provides evidence that proteins from this family are in-
volved in virus host range determination.
Thus, cowpox virus contains in its genome all three
known host range genes of orthopoxviruses and a large
set of additional genes that are structurally similar to the
hr genes. Thus, collectively, these genes provide CPV
with an extremely wide host range in nature, contributing
to a stable maintenance in the biosphere.
Ring canal protein (RCP) family
Numerous genes encoding proteins from this family
are located only in the terminal genome regions of or-
thopoxviruses and leporipoxviruses (myxoma virus and
Shope fibroma virus). In the regions of the CPV-GRI
genome under study, 8 such genes (Fig. 15) have been
identified. Most proteins of this family have extended
dimensions (approx. 500 aa) and six specific tandem
repeats of 40–55 aa are located in the C-terminal regions
(Senkevich et al., 1993). These proteins can be charac-
terized as having only moderate homology (20–25%) but
homology is found almost throughout the protein se-
quence.
Cell analogs of these proteins had been identified:
MIPP, a protein being expressed in murine placenta, and
the Kelch protein that participates in oogenesis of Dro-
sophila melanogaster (Xue and Cooley, 1993). The latter
is also called the RCP. It binds with actin microfilaments
located on the surface of the ring canals that connect the
oocyte with the nurse cells and probably participates in
the regulation of exchange of cytoplasmic components
between these cells.
Although the functions of proteins from this numerous
family are encoded in the genomes of orthopoxviruses
and leporipoxviruses, their function(s) has not yet been
established. However, their structural similarity to the
RCP makes it possible to assume that these proteins are
capable of binding with the cytoskeleton elements. It
should be noted that in the VAR genome the RCP family
is represented only with considerably reduced potential
ORFs, and part of the ORFs are not present at all. In the
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454 SHCHELKUNOV ET AL.
FIG. 14. Comparison of amino acid sequences of ankyrin repeats of cowpox virus proteins. Location of the genes for these proteins are shown in
Fig. 13. Black blocks indicate the conservative amino acid residues in the sequences studied. Positions of the beginning and the end of ankyrin
repeats in the corresponding viral proteins are shown to the left and right. Asterisk to the right of the repeat indicates that it is followed by another
ankyrin repeat without interruption. Shown in the two bottom lines are the consensus sequence for ankyrin repeat of poxviruses (POX) inferred in this
work and a similar sequence for ankyrin-like proteins (ANK) published earlier (Lux et al., 1990).
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VAC genome, analogs of ORFs D7L, D11L, and B19R
CPV-GRI are not present either (Fig. 15), but four of the
remaining five genes have similar size and have a high
homology index (97–99%) to the respective CPV proteins
(Table 1).
We believe that such properties of genes from the RCP
family as (1) location in the variable regions of viral
genome, (2) being numerous, and (3) not essential to
virus propagation on cell cultures bears resemblance to
properties of the ankyrin-like proteins. By all appearance,
the proteins of these two families are involved in orga-
nization of a multifactor, complex system of interactions
of viral proteins among themselves and with the cellular
components. We predict that such interactions may pro-
vide a wide range of tissues and host animals that are
sensitive to cowpox virus as well as determining a ‘‘fa-
vored-host’’ pattern for this virus. Disruption of most of
ORFs from these two families in VAR may have been the
cause of the marked narrowing of host range and VAR’s
becoming an ‘‘aggressor’’ type.
The results obtained for the ORFs of the RCP family
together with the above-described data on ankyrin-like
proteins and the members of the TNF receptor family
suggest that evolutionarily the cowpox virus is the best
adaptation to the existence of the poxviruses under the
everchanging conditions of the biosphere and is more
ancient than variola and vaccinia viruses.
MATERIALS AND METHODS
The CPV GRI-90 strain (CPV-GRI) used in our se-
quence analysis was kindly provided by Dr. S. S. Maren-
nikova; it was isolated in 1990 from a young female
patient who got infected from an ill mole (Marennikova et
al., 1996). Propagation and purification of virus, isolation
of viral DNA, cloning of genome DNA restriction frag-
ments, and screening of clones obtained were per-
formed as described previously (Shchelkunov et al., 1991,
1993c).
The cloning of the terminal KpnI fragment was per-
formed as follows: the KpnI digest of viral DNA was
denatured by boiling for 10 min and then quenched; only
terminal fragments with covalently closed DNA chains
were renatured. Renaturation products were separated
by preparative electrophoresis in a 0.6% agarose gel.
The KpnI fragment was cut out from the gel and eluted on
a dialysis membrane. The fragment was then treated
with nuclease S1 for 2 min, which resulted in the hydro-
lysis of single-stranded DNA chains in the terminal hair-
pin region. The DNA preparation obtained was pro-
cessed with a Klenow fragment of Escherichia coli DNA
polymerase I in the presence of all four deoxyribonucleo-
side triphosphates in order to ‘‘blunt’’ the ends of the DNA
molecules; the DNA was then inserted into the vector
plasmid pUC18 (Yanisch-Perron et al., 1985), after pro-
cessing with the restriction enzyme SmaI.
Identification of the primary structure of the DNA
fragments was carried out as described previously
(Shchelkunov et al., 1993c). Computer analysis of data
obtained was done using the ‘‘Alignment Service’’ pro-
gram (Resenchuk and Blinov, 1995). The map of se-
quenced DNA fragments of CPV-GRI is shown in Fig. 1.
Joint points of nonoverlapping fragments were amplified
by PCR with subsequent sequencing. Nucleotide se-
quences of CPV-GRI presented here have been depos-
ited at the international data bank:EMBL Data Library
under Accession Nos. Y11842 and Y15035.
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